Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B R Zetter
miR-135a Contributes to Paclitaxel Resistance in Tumor Cells Both in Vitro and in Vivo
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Targeted Delivery of Paclitaxel to Tumor Cells: Synthesis and in Vitro Evaluation
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2
Oncology Reports
Medicine
Cancer Research
Oncology
MiR-1204 Sensitizes Nasopharyngeal Carcinoma Cells to Paclitaxel Bothin Vitroandin Vivo
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
MLN8054, an Inhibitor of Aurora a Kinase, Induces Senescence in Human Tumor Cells Both in Vitro and in Vivo
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Resistance of Human Tumor Cells in Vitro to Oxidative Cytolysis.
Journal of Clinical Investigation
Medicine
Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells
PLoS ONE
Multidisciplinary
The Alkylphospholipid, Perifosine, Radiosensitizes Prostate Cancer Cells Both in Vitro and in Vivo
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
The Hedgehog Inhibitor GANT61 Sensitizes Prostate Cancer Cells to Ionizing Radiation Both in Vitro and in Vivo
Oncotarget
Oncology
Dysregulation of miR-106a and miR-591 Confers Paclitaxel Resistance to Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology